Defining the Potency of DTG/3TC for Suppressed HIV Patients in Real-life: the DUALING Study | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Defining the Potency of DTG/3TC for Suppressed HIV Patients in Real-life: the DUALING Study	AIDS, Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease	Active, not recruiting	Not stated	2024-12-20		NCT04707326

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Admiraal de Ruyter Hospital	1
Catharina Ziekenhuis Eindhoven	45
Elisabeth-TweeSteden Ziekenhuis	14
Erasmus Medical Center	271
Haaglanden Medical Centre	17
Maasstad Hospital	14
Medisch Spectrum Twente	33
Rijnstate Hospital	42
Spaarne Gasthuis	16

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Admiraal De Ruyter Ziekenhuis	Goes	Netherlands	15
Catharina Ziekenhuis	Eindhoven	Netherlands	43
Elisabeth Tweesteden Hospital	Tilburg	Netherlands	2
Erasmus MC	Rotterdam	Netherlands	5
Maasstad Hospital	Rotterdam	Netherlands	9
MC Haaglanden	Rotterdam	Netherlands	1
Medisch Spectrum Twente	Enschede	Netherlands	36
Rijnstate Hospital	Arnhem	Netherlands	16
Spaarne Gasthuis	Haarlem	Netherlands	15